Keywords: Tumors (Pre-Treatment), Brain
Motivation: Alterations in glutamatergic and GABAergic (gamma-aminobutyric acid) mechanisms render peritumoral neuronal networks of infiltrating glioma hyper-excitable and more prone to seizures.
Goal(s): Glutamate, glutamine, glutathione (GSH), and GABA are therefore key metabolites in glioma-associated epilepsy.
Approach: Nowadays, J-editing MR spectroscopy is the primary technique in the detection of low-abundant metabolites (e.g., GSH, GABA) that overlap with more prominent signals. We used this technique combined with sLASER sequence (MEGA-sLASER) to improve localization accuracy and showed its reliability/repeatability for GSH and GABA quantification in glioblastoma, IDH-wildtype.
Results: This approach could foster our understanding of the biological effects of novel drugs targeting tumor-associated epilepsy.
Impact: MEGA-sLASER might improve the detectability and MRS localization accuracy of low-abundant metabolites (GSH, GABA) even in rather small, heterogeneous solid tumors. Here, we show the reliability/reproducibility of this method in the investigation of glioma-associated epilepsy in glioblastoma patients.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords